Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celularity (CELU) Other Operating Expenses (2020 - 2025)

Celularity (CELU) has disclosed Other Operating Expenses for 6 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 2.99% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $21.6 million, up 30.32%, while the annual FY2025 figure was $21.6 million, 30.32% up from the prior year.
  • Other Operating Expenses hit $7.8 million in Q4 2025 for Celularity, up from $4.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $87.1 million in Q3 2023 and bottomed at -$45.7 million in Q3 2021.
  • Average Other Operating Expenses over 5 years is $2.1 million, with a median of $4.3 million recorded in 2024.
  • On a YoY basis, Other Operating Expenses climbed as much as 9186.17% in 2021 and fell as far as 930.33% in 2021.
  • Celularity's Other Operating Expenses stood at -$18.1 million in 2021, then plummeted by 140.08% to -$43.4 million in 2022, then surged by 67.76% to -$14.0 million in 2023, then surged by 153.76% to $7.5 million in 2024, then increased by 2.99% to $7.8 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $7.8 million, $4.3 million, and $5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.